Products

Compare Products

Side-by-side comparison of veterinary products

1 Products
Anipryl (selegiline hydrochloride tablets)
Anipryl (selegiline hydrochloride tablets)
Pharmaceutical

Tablet

Zoetis

Selegiline hydrochloride

Search to add a product

Search to add a product

Attribute Anipryl (selegiline hydrochloride tablets)
Image Anipryl (selegiline hydrochloride tablets)
Trade Name Anipryl (selegiline hydrochloride tablets)

أنيبريل أقراص سيليجيلين هيدروكلوريد للكلاب لعلاج الخرف البيطري ومتلازمة كوشينغ
Product Type Pharmaceutical
Dosage Form Tablet
Manufacturer Zoetis
Active Ingredients
Diseases —
Package Size Bottles of 30 tablets containing 2 mg, 5 mg, 10 mg, 15 mg, or 30 mg selegiline HCl
Storage Conditions Store at controlled room temperature 20° to 25°C (68° to 77°F). Protect from light and moisture.
Dosages

Dog

  • For CDS: 0.5 to 1.0 mg/kg once daily in the morning; For PDH: 1.0 mg/kg once daily in the morning, may be increased to 2.0 mg/kg if needed (Oral) — Administer daily in the morning. Re-evaluate response at 4 weeks and 8 weeks
Withdrawal Periods —
Indications
  • Control of clinical signs associated with canine cognitive dysfunction syndrome (CDS).
  • Control of clinical signs associated with uncomplicated canine pituitary-dependent hyperadrenocorticism (PDH / Cushing's disease).
Contraindications
  • Contraindicated in dogs with known hypersensitivity to selegiline hydrochloride.
  • Do not use concurrently with meperidine, tramadol, other opioids, SSRIs, tricyclic antidepressants, or amitraz.
Precautions
  • Allow at least 14 days washout period after discontinuation of fluoxetine or tricyclic antidepressants before starting Anipryl. Concurrent use with alpha-2 agonists requires careful monitoring.
Side Effects
  • Vomiting, diarrhea, restlessness, agitation, anorexia, lethargy, or salivation.

This website uses cookies to ensure you get the best experience.